F. Ishimaru

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
F Ishimaru, F. Ishimaru, Fumihiko Ishimaru
Publication record
83 papers · 1,625 citations · H-index 26

PAPERS

With regard to our manuscripts on the commercial saliva substitute, Oralbalance®—its formula has been changed
20140 citationsauthor #9
Bacterial substitution of coagulase-negative staphylococci for streptococci on the oral mucosa after hematopoietic cell transplantation
201130 citationsauthor #3
Total bacterial counts on oral mucosa after using a commercial saliva substitute in patients undergoing hematopoietic cell transplantation
20106 citationsauthor #9
The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis
200911 citationsauthor #21
Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia
200924 citationsauthor #8
Appearance of multidrug-resistant opportunistic bacteria on the gingiva during leukemia treatment.
200822 citationsauthor #4
Evaluation of xerostomia in hematopoietic cell transplantation by a simple capacitance method device
20087 citationsauthor #7
Antimicrobial effects of the saliva substitute, Oralbalance®, against microorganisms from oral mucosa in the hematopoietic cell transplantation period
200819 citationsauthor #9
Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
200713 citationsauthor #5
Characterization of the short isoform of Helios overexpressed in patients with T‐cell malignancies
200721 citationsauthor #2
Serum cytokine concentrations and acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: concurrent measurement of ten cytokines and their respective ratios using cytometric bead array.
200637 citationsauthor #9
Evolution of Rituximab as “Standard” Therapy in Patients (pts) with Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) in Japan: An Analysis from West-Japan Hematology/Oncology Group (West-JHOG) NHL Outcomes Project.
20060 citationsauthor #17
Calcineurin Inhibitor—Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
200636 citationsauthor #12
Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors.
200615 citationsauthor #6
Early Kinetics of Engraftment Following Reduced-Intensity Stem Cell Transplantation: Fludarabine and Cyclophosphamide Versus Fludarabine and Busulfan.
20061 citationsauthor #2
Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non‐small‐cell lung cancer: Experience at a single institution
200610 citationsauthor #12
Minimal Residual Disease Detection by Real Time PCR of the Dominant-Negative Isoform of Ikaros in Patients with Acute Lymphoblastic Leukemia.
20060 citationsauthor #2
Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells
200546 citationsauthor #6
Aberrant Expression of Ikaros Induces T-Cell Leukemia/Lymphoma in Mice without Wild-Type Allelic Loss.
20050 citationsauthor #2
A Novel ALL-L3 Cell Line, BALM-25, Expressing Both Immunoglobulin Light Chains
20042 citationsauthor #6
[Clinical evaluation of cefozopran as treatment for febrile neutropenia].
20041 citationsauthor #15
Involvement of ERK1/2 and p38 MAP Kinase in Doxorubicin-Induced uPA Expression in Human RC-K8 Lymphoma and NCI-H69 Small Cell Lung Carcinoma Cells
200413 citationsauthor #8
Microarray Analysis of the Short Isoform of Ikaros Overexpressed in Patients with Hematologic Malignancies.
20040 citationsauthor #2
Prevalent hyper-methylation of the CDH13 gene promoter in malignant B cell lymphomas.
200426 citationsauthor #7
Elevation of serum hepatocyte growth factor during granulocyte colony‐stimulating factor‐induced peripheral blood stem cell mobilization
200455 citationsauthor #2
Peripheral blood circulating immature cell counts predict CD34+ cell yields in G‐CSF‐induced PBPC mobilization in healthy donors
200425 citationsauthor #19
Induction of TNF-α, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells
200350 citationsauthor #7
The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5′‐untranslated region
200316 citationsauthor #2
Over‐expression of short isoforms of Helios in patients with adult T‐cell leukaemia/lymphoma
200320 citationsauthor #2
Over‐expression of the dominant‐negative isoform of Ikaros confers resistance to dexamethasone‐induced and anti‐IgM‐induced apoptosis
200314 citationsauthor #2
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
200330 citationsauthor #7
Acute lymphoblastic leukemia with large molecular ACTH production
20039 citationsauthor #7
Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization
200316 citationsauthor #2
Simultaneous induction of matrix metalloproteinase‐9 and interleukin 8 by all‐trans retinoic acid in human PL‐21 and NB4 myeloid leukaemia cells
200233 citationsauthor #5
Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia.
200240 citationsauthor #2
Expression of Ikaros isoforms in patients with acute myeloid leukemia. Authors' reply
20020 citationsauthor #1
Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
200211 citationsauthor #8
Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G–CSF plus chemotherapy‐induced mobilization
200226 citationsauthor #16
Establishment and characterization of new B-cell precursor leukemia cell line NALM-35
20021 citationsauthor #5
Thymic Epithelial Hyperplasia with Nodular Sclerosis Hodgkin's Disease
20023 citationsauthor #7
Expression of minor histocompatibility antigen, HA-1, in solid tumor cells
200238 citationsauthor #7
Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma.
200211 citationsauthor #5
Successful Treatment of Progressive NK cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
200218 citationsauthor #8
Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8
20028 citationsauthor #10
Expression of Ikaros isoforms in patients with acute myeloid leukemia.
20026 citationsauthor #1
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis.
200249 citationsauthor #8
High-dose Chemotherapy with Hematopoietic Stem Cell Transplantation is Effective for Nasal and Nasal-type CD56+ Natural Killer Cell Lymphomas
200142 citationsauthor #12
Synergistic effects of pegylated recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor on mobilization of hematopoietic progenitor and stem cells with long-term repopulating ability into peripheral blood in mice
200111 citationsauthor #4
Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21)
20015 citationsauthor #7
Induction of urokinase‐type plasminogen activator by the anthracycline antibiotic in human RC‐K8 lymphoma and H69 lung‐carcinoma cells
200117 citationsauthor #6
Huge skin tumor diffuse large cell lymphoma associated with essential thrombocytosis.
20011 citationsauthor #3
Administration of granulocyte colony-stimulating factor induces hyporesponsiveness to lipopolysaccharide and impairs antigen-presenting function of peripheral blood monocytes.
20019 citationsauthor #8
Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation
200148 citationsauthor #9
Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
200134 citationsauthor #9
[An adult patient with varicella preceded by acute thrombocytopenia].
20016 citationsauthor #4
Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome.
20007 citationsauthor #7
Adult B-Cell Acute Lymphoblastic Leukemia Dominant Negative Isoform of the Ikaros Gene in Patients with Updated
20001 citationsauthor #2
Dominant-negative isoforms of helios in patients with adult T cell leukemia/lymphoma
20000 citationsauthor #2
Ikaros expression in human hematopoietic lineages.
200027 citationsauthor #2
Allogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: a single-center experience.
20000 citationsauthor #10
Granulocyte colony-stimulating factor and lineage-independent modulation of VLA-4 expression on circulating CD34+ cells.
20005 citationsauthor #4
G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function
200048 citationsauthor #8
Successful engraftment of allogeneic peripheral blood stem cell transplant after nonmyeloablative preparative regimen with cytarabine and cyclophosphamide: report of 2 cases.
20000 citationsauthor #10
Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
2000138 citationsauthor #2
Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein–Barr virus infection
200031 citationsauthor #11
Chemoprotectants ameliorate chemotherapy-associated toxicity at specific sites
20000 citationsauthor #4
Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
1999123 citationsauthor #2
Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period
19991 citationsauthor #19
Patients with Chronic Myelogenous Leukemia Decreases in Ikaros Activity Correlate with Blast Crisis in Updated
19990 citationsauthor #2
Advances in Brief Decreases in Ikaros Activity Correlate with Blast Crisis in Patients with Chronic Myelogenous Leukemia
19990 citationsauthor #2
Monitoring of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation
199972 citationsauthor #15
Additional translocation (8;21)(q22;q22) in a patient with Philadelphia‐positive chronic myelogenous leukaemia in the blastic phase
199931 citationsauthor #3
Establishment and characterization of a novel ALL-L3 cell line (BALM-18): induction of apoptosis by anti-IgM and inhibition of apoptosis by bone marrow stroma cells.
199910 citationsauthor #5
Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
19996 citationsauthor #9
Molecular characterization of total kininogen deficiency in Japanese patients.
19994 citationsauthor #1
Allogeneic peripheral blood stem cell transplantation for the treatment of refractory follicular lymphoma.
19983 citationsauthor #3
Common clonal origin of lymphocytes and plasma cells in splenic lymphoma with villous lymphocytes
19975 citationsauthor #14
G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF.
199731 citationsauthor #9
The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms.
199747 citationsauthor #1
Analysis of the human CD10/neutral endopeptidase 24.11 promoter region: two separate regulatory elements.
199543 citationsauthor #1
HTLV-I associated lung cancer (HALC): Significance of HABA as a precancerous stage@@@前癌病変としてのHABAの重要性について
19910 citationsauthor #6
Molecular genetic survey of 5 kindreds with kininogen deficiency in Japan: 2. Southern blot analysis of the kininogen gene@@@第2編キニノゲン遺伝子のSouthern blottingによる検討
19900 citationsauthor #1
Molecular genetic survey of 5 kindreds with kininogen deficiency in Japan
19900 citationsauthor #1

TIMELINE

1990 0 citations

1991 0 citations

1995 43 citations

1997 83 citations

1998 3 citations

1999 247 citations

2000 257 citations

2001 173 citations

2002 244 citations

2003 155 citations

2004 122 citations

2005 46 citations

2006 99 citations

2007 34 citations

2008 48 citations

2009 35 citations

2010 6 citations

2011 30 citations

2014 0 citations

F. Ishimaru

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT